We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

67 hedge funds and large institutions have $63.3M invested in IVERIC bio, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $305K | Put options by funds: $189K

13% more capital invested

Capital invested by funds: $56.3M → $63.3M (+$7.06M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 77 → 67 (-10)

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
67
Holders Change
-10
Holders Change %
-12.99%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
18
Reduced
25
Closed
17
Calls
$305K
Puts
$189K
Net Calls
+$116K
Net Calls Change
-$1.06M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.6M
2
LCM
Laurion Capital Management
New York
+$1.15M
3
First Manhattan
First Manhattan
New York
+$1.15M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.06M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$693K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$783K
2
BIM
Bogle Investment Management
Massachusetts
-$706K
3
QIM
Quantitative Investment Management
Virginia
-$658K
4
PAM
Panagora Asset Management
Massachusetts
-$619K
5
NI
Numeric Investors
Massachusetts
-$570K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$160K -$39.3K -14,536 -20%
Federated Hermes
27
Federated Hermes
Pennsylvania
$159K +$2.15K +797 +1%
Barclays
28
Barclays
United Kingdom
$158K -$27.8K -10,306 -16%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$154K +$4.3K +1,591 +3%
Northern Trust
30
Northern Trust
Illinois
$150K -$35.1K -12,982 -20%
Creative Planning
31
Creative Planning
Kansas
$150K +$16.6K +6,134 +13%
ARTA
32
A.R.T. Advisors
New York
$149K -$321K -119,060 -69%
DCM
33
DAFNA Capital Management
California
$141K +$135K +50,000 New
VF
34
Virtu Financial
New York
$140K +$134K +49,634 New
Two Sigma Advisers
35
Two Sigma Advisers
New York
$130K -$407K -150,644 -77%
State Street
36
State Street
Massachusetts
$129K -$32.1K -11,900 -21%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$123K – – –
Morgan Stanley
38
Morgan Stanley
New York
$120K -$278K -102,821 -71%
JP Morgan Chase
39
JP Morgan Chase
New York
$88K -$23.9K -8,842 -21%
DekaBank Deutsche Girozentrale
40
DekaBank Deutsche Girozentrale
Germany
$74K – – –
ProShare Advisors
41
ProShare Advisors
Maryland
$57K +$4.97K +1,842 +10%
GF
42
Gabelli Funds
New York
$54K – – –
ROTUOC
43
Regents of the University of California
California
$45K +$43.5K +16,110 New
Macquarie Group
44
Macquarie Group
Australia
$42K +$40.5K +15,000 New
NCCM
45
Nine Chapters Capital Management
New Jersey
$38K +$5.94K +2,200 +19%
Bank of America
46
Bank of America
North Carolina
$35K -$124K -46,080 -79%
Wells Fargo
47
Wells Fargo
California
$33K +$31.5K +11,650 +11,768%
CAN
48
Cetera Advisor Networks
California
$32K – – –
PCM
49
Prelude Capital Management
New York
$28K +$2.16K +800 +9%
HCM
50
Highlander Capital Management
New Jersey
$17K – – –
1
2
3 4

ISEE Hedge Fund Activity: Q3 2017 in Review

67 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2017, worth a combined $63.3M — up 13% from $56.3M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ISEE and 8 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 18 added.

The largest buyer was Armistice Capital, adding an estimated $2.6M. The largest seller was Goldman Sachs, cutting an estimated $783K.

  • 67 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2017, down from 77 in Q2 2017.
  • Funds reported $63.3M of IVERIC bio, Inc. Common Stock stock for Q3 2017, up 13% quarter-over-quarter.
  • 8 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2017 and 17 closed out, a net change of -9 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2017 was Armistice Capital, an estimated $2.6M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2017 was Goldman Sachs, an estimated $783K sold.

Based on aggregated 13F filings for Q3 2017.